The device-aided intrajejunal delivery of levodopa–entacapone–carbidopa intestinal gel the treatment of Parkinson’s disease: overview of efficacy and safety

Device-aided therapies (DATs) have been developed to provide continuous drug delivery (CDD) to people with advanced Parkinson's disease (PD) whose symptoms can no longer be effectively managed with oral or transdermal therapy. Intrajejunal infusion of levodopa-carbidopa intestinal gel (LCIG), d...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Expert review of medical devices Jg. 22; H. 6; S. 533 - 544
Hauptverfasser:	Popławska-Domaszewicz, Karolina, Metta, Vinod, Odin, Per, Chaudhuri, K Ray
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	England 03.06.2025
Schlagworte:	Antiparkinson Agents - administration & dosage Antiparkinson Agents - therapeutic use Carbidopa - administration & dosage Carbidopa - adverse effects Carbidopa - therapeutic use Catechols - administration & dosage Catechols - adverse effects Catechols - therapeutic use Clinical Medicine Drug Combinations Drug Delivery Systems - instrumentation Gels Humans Jejunum Klinisk medicin Levodopa - administration & dosage Levodopa - adverse effects Levodopa - therapeutic use Medical and Health Sciences Medicin och hälsovetenskap Neurologi Neurology Nitriles - administration & dosage Nitriles - adverse effects Nitriles - therapeutic use Parkinson Disease - drug therapy Treatment Outcome advanced parkinson’s disease infusion pump Device-aided therapy LECIGON medical device levodopa–carbidopa–entacapone
ISSN:	1743-4440, 1745-2422, 1745-2422
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!